What Has Been The Evolution of the Deep Brain Stimulation Systems Market in Recent Years?
The deep brain stimulation systems market has seen considerable growth due to a variety of factors.
• The market for deep brain stimulation systems has seen a remarkable expansion in recent times. The market is projected to rise from $2.53 billion in 2024 to $2.79 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.1%.
The previous growth can be ascribed to factors such as a growing preference for less invasive procedures among the populace, escalated demand for minimally invasive surgery in developed nations, an increased necessity for minimally invasive surgical methods, widespread occurrence of conditions like Parkinson's disease and epilepsy, and a rising incidence of neurological disorders.
What Is the Forecasted Market Size and Growth Rate for The Deep Brain Stimulation Systems Market Size In The Coming Years?
The deep brain stimulation systems market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the deep brain stimulation systems market to experience significant expansion in the coming years. The market's value is projected to reach $4.16 billion by 2029, with a compound annual growth rate (CAGR) of 10.6%.
This anticipated growth during the forecast period can be ascribed to factors such as the increase in the elderly population, the escalating prevalence of neurological disorders worldwide, demographic aging, the growing acceptance of neurostimulation therapies, and the development of healthcare infrastructure. Key trends predicted for the forecast period encompass technological progress in deep brain stimulation devices, advancements in technology, an emphasis on non-motor symptoms, miniaturization and advanced materials, wireless connectivity and remote monitoring, and multimodal therapies.
What Factors Are Driving Growth In The Deep Brain Stimulation Systems Market?
The escalation in neurologic condition cases is projected to boost the expansion of the deep brain stimulation systems market in future. Neurological disorders encompass a diverse range of diseases that impact the autonomic, peripheral, and central nervous systems of the body. Deep brain stimulation systems are utilized in neurosurgical processes to transmit electrical stimulation to the targeted area to change or adjust neural operations and obtain an adjustable, reversible, and therapeutic influence. For instance, there was a reported estimate by the Parkinson's Foundation, an organization based in the US, that nearly 90,000 people were diagnosed with PD in March 2023. This is an increase of 50% from the previously approximated 60,000 annual diagnoses. Hence, the growing incidence of neurologic conditions is propelling the expansion of the deep brain stimulation systems market.
What Are The Main Segments Of The Global Deep Brain Stimulation Systems Market?
The deep brain stimulation systems market covered in this report is segmented –
1) By Product: Single Channel, Dual Channel
2) By Application: Parkinson's Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications
3) By End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users
Pre-Book The Deep Brain Stimulation Systems Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Deep Brain Stimulation Systems Market?
Leading firms in the deep brain stimulation systems market are pushing the boundaries of innovation, creating advanced technologies such as deep brain stimulation (DBS) systems, geared towards patients suffering from movement disorders. Deep Brain Stimulation is a surgical procedure that employs an implanted device to deliver electrical impulses to specific brain regions. For example, in January 2024, Abbott Laboratories, a prominent US healthcare and medical devices corporation, unveiled the Liberta RC DBS system, the smallest rechargeable DBS device worldwide that comes with remote programming capabilities, designed to help those affected by movement disorders. The Liberta RC DBS system stands out as the only rechargeable, pioneering connected care technology in the U.S, allowing patients to maintain contact with their doctors, ensure optimal device performance and configuration, and fetch necessary treatment adjustments remotely without the need for an office visit.
Who Are the Key Players In The Deep Brain Stimulation Systems Market?
Major companies operating in the deep brain stimulation systems market report are:
• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Quest Diagnostics Inc.
• St. Jude Medical Inc.
• Stanford Health Care
• Associated Regional and University Pathologists Inc.
• LivaNova PLC
• OPKO Health Inc.
• Nordic Laboratories
• Myriad Genetics Inc.
• Nevro Corporation
• Genomic Health
• Mayo Medical Laboratories
• Foundation Medicine Inc.
• SceneRay Co.
• ACM Global Laboratories
• Neuropace Inc.
• American Esoteric Laboratories
• Nexstim Oy
• Aleva Neurotherapeutics S.A.
• NeuroSigma Inc.
• Beijing PINS Medical Co. Ltd.
• BioMONTR Labs
• Functional Neuromodulation Ltd.
• Miraca Holdings Inc.
• Nuvectra Corporation
What Is The Most Dominant Region In The Deep Brain Stimulation Systems Market?
North America was the largest region in the deep brain stimulation systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
